312 related articles for article (PubMed ID: 26731758)
1. Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.
Williams PL; Hazra R; Van Dyke RB; Yildirim C; Crain MJ; Seage GR; Civitello L; Ellis A; Butler L; Rich K;
AIDS; 2016 Jan; 30(1):133-44. PubMed ID: 26731758
[TBL] [Abstract][Full Text] [Related]
2. Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study.
Williams PL; Yildirim C; Chadwick EG; Van Dyke RB; Smith R; Correia KF; DiPerna A; Seage GR; Hazra R; Crowell CS;
Lancet HIV; 2020 Jan; 7(1):e49-e58. PubMed ID: 31740351
[TBL] [Abstract][Full Text] [Related]
3. Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the Caribbean.
Spaulding AB; Yu Q; Civitello L; Mussi-Pinhata MM; Pinto J; Gomes IM; Alarcón JO; Siberry GK; Harris DR; Hazra R
AIDS Res Hum Retroviruses; 2016 Apr; 32(4):349-56. PubMed ID: 26879281
[TBL] [Abstract][Full Text] [Related]
4. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
[TBL] [Abstract][Full Text] [Related]
5. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
[TBL] [Abstract][Full Text] [Related]
6. In-utero exposure to antiretrovirals and neurodevelopment among HIV-exposed-uninfected children in Botswana.
Chaudhury S; Mayondi GK; Williams PL; Leidner J; Shapiro R; Diseko M; Ajibola G; Holding P; Tepper V; Makhema J; Petlo C; Seage GR; Lockman S; Kammerer B
AIDS; 2018 Jun; 32(9):1173-1183. PubMed ID: 29547434
[TBL] [Abstract][Full Text] [Related]
7. A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothers.
Williams PL; Seage GR; Van Dyke RB; Siberry GK; Griner R; Tassiopoulos K; Yildirim C; Read JS; Huo Y; Hazra R; Jacobson DL; Mofenson LM; Rich K;
Am J Epidemiol; 2012 May; 175(9):950-61. PubMed ID: 22491086
[TBL] [Abstract][Full Text] [Related]
8. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants.
Rice ML; Zeldow B; Siberry GK; Purswani M; Malee K; Hoffman HJ; Frederick T; Buchanan A; Sirois PA; Allison SM; Williams PL;
Pediatr Infect Dis J; 2013 Oct; 32(10):e406-13. PubMed ID: 24067563
[TBL] [Abstract][Full Text] [Related]
10. Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants.
Bae WH; Wester C; Smeaton LM; Shapiro RL; Lockman S; Onyait K; Thior I; Essex M
AIDS; 2008 Aug; 22(13):1633-40. PubMed ID: 18670224
[TBL] [Abstract][Full Text] [Related]
11. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
Thorne C; Newell ML
Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
[TBL] [Abstract][Full Text] [Related]
12. Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age.
Nozyce ML; Huo Y; Williams PL; Kapetanovic S; Hazra R; Nichols S; Hunter S; Smith R; Seage GR; Sirois PA;
Pediatr Infect Dis J; 2014 Nov; 33(11):1128-33. PubMed ID: 25361407
[TBL] [Abstract][Full Text] [Related]
13. The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs.
Van Dyke RB; Chadwick EG; Hazra R; Williams PL; Seage GR
Front Immunol; 2016; 7():199. PubMed ID: 27242802
[TBL] [Abstract][Full Text] [Related]
14. Safety of antiretroviral drug therapy in Jamaican children with HIV/AIDS.
Pryce C; Pierre RB; Steel-Duncan J; Evans-Gilbert T; Palmer P; Moore J; Rodriguez B; Christie CD
West Indian Med J; 2008 Jun; 57(3):238-45. PubMed ID: 19583122
[TBL] [Abstract][Full Text] [Related]
15. Rapid disease progression in HIV-1 perinatally infected children born to mothers receiving zidovudine monotherapy during pregnancy. The Italian register for HIV Infection in Children.
AIDS; 1999 May; 13(8):927-33. PubMed ID: 10371173
[TBL] [Abstract][Full Text] [Related]
16. Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected.
Crowell CS; Williams PL; Yildirim C; Van Dyke RB; Smith R; Chadwick EG; Seage GR; Diperna A; Hazra R;
AIDS; 2020 Jul; 34(9):1377-1387. PubMed ID: 32310900
[TBL] [Abstract][Full Text] [Related]
17. Drug safety during pregnancy and in infants. Lack of mortality related to mitochondrial dysfunction among perinatally HIV-exposed children in pediatric HIV surveillance.
Lindegren ML; Rhodes P; Gordon L; Fleming P; ;
Ann N Y Acad Sci; 2000 Nov; 918():222-35. PubMed ID: 11131709
[TBL] [Abstract][Full Text] [Related]
18. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
19. [In-utero antiretroviral exposure and mitochondrial toxicity in a cohort of uninfected infants born to HIV-1-infected women].
Fernández Ibieta M; Cano JM; Amador JT; González-Tomé MI; Martín SG; Gómez MN; de José MI; Beceiro J; Iglesias E; Prieto L; Santos MJ; Guardia NM; Roa MA; Regidor J
An Pediatr (Barc); 2010 Oct; 73(4):180-8. PubMed ID: 20951949
[TBL] [Abstract][Full Text] [Related]
20. Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United States.
Kirmse B; Yao TJ; Hofherr S; Kacanek D; Williams PL; Hobbs CV; Hazra R; Borkowsky W; Van Dyke RB; Summar M
AIDS Res Hum Retroviruses; 2016 Apr; 32(4):339-48. PubMed ID: 26548585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
